EPIRUS Biopharmaceuticals (EPRSQ) 10-K2013 FY Annual report

Filed: 14 Mar 14, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: bowel, brought, clarifying, correspondingly, developmental, efficiency, erythromelalgia, exceeded, explore, Imaging, implicated, inInternal, Ireland, length, LEP, light, Lincoln, LPC, necessarily, NOL, notwithstanding, par, parent, Park, penalty, prepay, split, spun, stimuli, stream, subunit, successor, timeline, unanimously, unmet, upper, visceral

Removed: Abbreviated, accrue, Allergy, analyzed, analyzer, ANDA, anniversary, announcement, ASC, asserted, asserting, assigned, attempted, attenuating, averaged, billion, black, book, box, brand, branded, capitalized, certification, Christopher, Cole, column, combining, compare, complaint, composite, compound, concentrated, consistent, contracted, contraindication, controlling, cooperate, Corrigan, Counsel, court, created, customized, depending, depression, disorderly, District, dorsal, enhanced, escrow, exclusivity, expedite, factor, favor, flexibility, force, Gallen, Germany, goodwill, grantee, Holdback, horn, hyperexcitable, immaterial, implanted, incoming, incremental, ingredient, input, interruption, intrathecal, intravenously, invalid, inventory, IV, Jason, Jersey, lawsuit, licensee, linked, Mark, marketability, membership, Merck, mixed, monetize, morphine, nausea, negatively, NIAID, nociceptive, Nonstatutory, observation, Orange, organic, osmotic, outweigh, Paragraph, people, Pharma, Prialt, profiled, protein, pump, randomized, rational, reaction, reassessed, reassessment, referenced, reformulation, relayed, repay, respiratory, retaining, retrospectively, returned, RSU, score, served, sparing, stated, strong, subsequently, summarize, tampered, thereof, traded, undesirable, unforeseeable, uniformly, uniquely, Vioxx, vomiting, withdraw, working

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

EPRSQ similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO

SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as principal executive officer and principal financial officer of Zalicus Inc. (the “Company”), do hereby certify that to their knowledge:

1) the Company’s Form 10-K for the fiscal year ended December 31, 2013 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2) the information contained in the Company’s Form 10-K for the fiscal year ended December 31, 2013 fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ MARK H.N. CORRIGAN

Mark H.N. Corrigan

President and Chief Executive Officer

(principal executive officer)

/s/ JUSTIN A. RENZ

Justin A. Renz

Executive Vice President and Chief Financial Officer

(principal financial and accounting officer)

Dated: March 14, 2014